Expedition Therapeutics, a biotechnology company focused on developing treatments for novel inflammatory and respiratory diseases, today announced the completion of an oversubscribed and upsized $165 million Series A financing. The round was co-led by Sofinnova Investments and Novo Holdings, with…
Perceptive Imaging, a global leader in clinical trial imaging solutions for the clinical research community, announced the appointment of Doug Fulling as Chief Executive Officer, succeeding David Herron, who led the company since 2022. Fulling officially assumed his new role…
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company focused on developing transformative gene therapies for rare neurological diseases, has announced a key regulatory update for its NGN-401 gene therapy in Rett syndrome. The company completed discussions with the U.S. Food…
The Institute of Clinical Research (The ICR) has announced the launch of its Company Membership Scheme, a strategic initiative aimed at strengthening professional development, collaboration, and engagement across the clinical research sector. The program is designed to broaden access to…
Stoke Space Technologies, the aerospace company developing fully reusable medium-lift launch vehicles, has announced a $510 million Series D funding round led by Thomas Tull’s US Innovative Technology Fund (USIT), alongside a $100 million debt facility led by Silicon Valley…
NTT Research, Inc., a division of NTT, announced a major breakthrough in photonics: its Physics and Informatics (PHI) Lab, in collaboration with Cornell University and Stanford University, has developed the world’s first programmable nonlinear photonic waveguide. Unlike conventional photonic devices…
E.R.I.C. Cancer Playbook, in partnership with Whole Health Oncology Institute, is unveiling a pioneering initiative to provide affordable access to Full Extract Cannabis Oil (FECO) for cancer patients, available exclusively in Colorado. The FECO Program, developed in collaboration with Native…
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., has announced major updates to its spatial biology product line, introducing a new class of spatial technology designed to make single-cell spatial analysis more accessible, versatile, and integrative.…
Thermo Fisher Scientific, the world leader in serving science, has introduced a groundbreaking laboratory developed test (LDT) designed to improve the detection and assessment of lung transplant rejection and injury. The new Molecular Microscope® Diagnostic System for Lung (MMDx® Lung)…
Charles River Laboratories International, Inc. and Toxys have announced a strategic collaboration to expand access to ReproTracker®, a cutting-edge, human stem cell-based in vitro assay designed to identify developmental toxicity hazards in pharmaceuticals and chemicals. The partnership aims to accelerate…